Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock

키워드

참고문헌 (39)

1. Aderem A, "Toll-like receptors in the induction of the innate immune response", Nature, 406, pp.782~787 (2000)
2. Reinhart K, "Markers of endothelial damage in organ dysfunction and sepsis", Crit Care Med, 30(5 Suppl), pp.S302~S312 (2002)
3. Tsujimoto H, "Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock", J Endotoxin Res, 10, pp.229~237 (2004)
4. Nishibori M, "Specific removal of monocytes from peripheral blood of septic patients by polymyxin B-immobilized filter column", Acta Med Okayama, 63, pp.65~69 (2009)
5. Wang Y, "Polymyxin B binds to anandamide and inhibits its cytotoxic effect", FEBS Lett, 470, pp.151~155 (2000)
6. Nakamura T, "Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor 4 and beta-thromboglobulin", Inflamm Res, 48, pp.171~175 (1999)
7. Nemoto H, "Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis", Blood Purif, 19, pp.361~368 (2001)
8. Nakamura T, "Polymyxin B-immobilized fiber hemoperfusion in patients with sepsis", Dial Tranplant, 32, pp.602~607 (2003)
9. Vincent JL, "A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection", Shock, 23, pp.400~405 (2005)
10. Cruz DN, "Early use of polymyxin B hemoperfusion in abdominal septic shock : the EUPHAS randomized controlled trial", JAMA, 301, pp.2445~2452 (2009)
11. Suzuki H, "Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure", Ther Apher, 6, pp.234~240 (2002)
12. Tani T, "Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients", World J Surg, 25, pp.660~668 (2001)
13. Ikeda T, "Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure", Ther Apher Dial, 8, pp.293~298 (2004)
14. Mitaka C, "A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock", Shock, 32, pp.478~483 (2009)
15. Nakamura T, "Suppression of high-mobility group box-1 and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients", J Crit Care, 26, pp.546~549 (2011)
16. Sugiura M, "Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock", J Intensive Care, 3, pp.14~ (2015)
17. Nakamura T, "Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis", Intensive Care Med, 30, pp.1838~1841 (2004)
18. Kushi H, "Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation", Crit Care, 9, pp.R653~R661 (2005)
19. Ueno T, "HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP", J Surg Res, 171, pp.183~190 (2011)
20. Kushi H, "Hemoperfusion with an immobilized polymyxin B column reduces the blood level of neutrophil elastase", Blood Purif, 24, pp.212~217 (2006)
21. Coudroy R, "Modulation by polymyxin-B hemoperfusion of inflammatory response related to severe peritonitis", Shock, 47, pp.93~99 (2017)
22. Bosmann A, "Therapeutic potential of targeting IL-17 and IL-23 in sepsis", Clin Transl Med, 1, pp.4~ (2012)
23. Flierl MA, "Adverse functions of IL-17A in experimental sepsis", FASEB J, 22, pp.2198~2205 (2008)
24. Cantaluppi V, "Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors", Intensive Care Med, 34, pp.1638~1645 (2008)
25. Bellomo R, "Defining and classifying acute renal failure : from advocacy to consensus and validation of the RIFLE criteria", Intensive Care Med, 33, pp.409~413 (2007)
26. Ono S, "Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber", Am J Surg, 188, pp.150~156 (2004)
27. Monneret G, "Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock", Intensive Care Med, 32, pp.1175~1183 (2006)
28. Srisawat N, "The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients", Crit Care, 22, pp.279~ (2018)
29. Wittkowski H, "Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome", Crit Care Med, 35, pp.1369~1375 (2007)
30. Takahashi G, "Changes in serum S100A12 and sRAGE associated with improvement of the PaO2", FiO2 ratio following PMX-DHP therapy for postoperative septic shock, 2011, pp.47, 135~140
31. Payen DM, "Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis : a multicenter randomized control trial", Intensive Care Med, 41, pp.975~984 (2015)
32. Dellinger RP, "Septic shock and elevated endotoxin level : the EUPHRATES randomized clinical trial", JAMA, 320, pp.1455~1463 (2018)
33. Klein DJ, "Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia : a post hoc analysis of the EUPHRATES trial", Intensive Care Med, 44, pp.2205~2212 (2018)
34. Shoji H, "Extracorporeal endotoxin removal for the treatment of sepsis : endotoxin adsorption cartridge(Toraymyxin)", Ther Apher Dial, 7, pp.108~114 (2003)
35. Yamashita C, "Clinical effects of a longer duration of polymyxin B-immobilized fiber column direct hemoperfusion therapy for severe sepsis and septic shock", Ther Apher Dial, 19, pp.316~323 (2015)
36. Miyamoto K, "Prolonged direct hemoperfusion using a polymyxin B immobilized fiber cartridge provides sustained circulatory stabilization in patients with septic shock : a retrospective observational before-after study", J Intensive Care, 5, pp.19~ (2017)
37. Kawazoe Y, "Mortality effects of prolonged hemoperfusion therapy using a polymyxin B-immobilized fiber column for patients with septic shock : a sub-analysis of the DESIRE trial", Blood Purif, 46, pp.309~314 (2018)
38. Mitaka C, "Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period", J Crit Care, 29, pp.728~732 (2014)
39. Berto P, "Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy", Blood Purif, 32, pp.331~340 (2011)

관련 논문AI추천